| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Departments of Surgical Oncology* and Cancer Biology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas; and the Department of Surgical Research, Children’s Hospital and Harvard Medical School, Boston, Massachusetts
Neuropilin-1 (NRP-1), a recently identified co-receptor for vascular endothelial growth factor, is expressed by several nongastrointestinal tumor types and enhances prostate cancer angiogenesis and growth in preclinical models. We investigated the expression and regulation of NRP-1 and the effect of NRP-1 overexpression on angiogenesis and growth of human colon adenocarcinoma by immunohistochemistry and in situ hybridization. NRP-1 was expressed in 20 of 20 human colon adenocarcinoma specimens but not in the adjacent nonmalignant colonic mucosa. By reverse transcriptase-polymerase chain reaction analysis, NRP-1 mRNA was expressed in seven of seven colon adenocarcinoma cell lines. Subcutaneous xenografts of stably transfected KM12SM/LM2 human colon cancer cells overexpressing NRP-1 led to increased tumor growth and angiogenesis in nude mice. In in vitro assays, conditioned medium from NRP-1-transfected cell lines led to an increase in endothelial cell migration, but did not affect endothelial cell growth. Epidermal growth factor (EGF) led to induction of NRP-1 in human colon adenocarcinoma cells and selective blockade of the epidermal growth factor receptor (EGFR) decreased constitutive and EGF-induced NRP-1 expression. Blockade of the Erk 1/2 and P38 mitogen-activated protein kinase signaling pathways also led to a decrease in constitutive and EGF-induced NRP-1 expression. These findings demonstrate the ubiquitous expression of NRP-1 in human colon cancer and suggest that NRP-1 may contribute to colon cancer angiogenesis and growth. This study also suggests that EGF and mitogen-activated protein kinase signaling pathways play an important role in NRP-1 regulation in colon cancer cells.
This article has been cited by other articles:
 |
|
 |
|
  A. Catalano, R. Lazzarini, S. Di Nuzzo, S. Orciari, and A. Procopio The Plexin-A1 Receptor Activates Vascular Endothelial Growth Factor-Receptor 2 and Nuclear Factor-{kappa}B to Mediate Survival and Anchorage-Independent Growth of Malignant Mesothelioma Cells Cancer Res., February 15, 2009; 69(4): 1485 - 1493. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Dallas, M. J. Gray, L. Xia, F. Fan, G. van Buren II, P. Gaur, S. Samuel, S. J. Lim, T. Arumugam, V. Ramachandran, et al. Neuropilin-2-Mediated Tumor Growth and Angiogenesis in Pancreatic Adenocarcinoma Clin. Cancer Res., December 15, 2008; 14(24): 8052 - 8060. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bae, S. Lu, C. A. Taglienti, and A. M. Mercurio Metabolic Stress Induces the Lysosomal Degradation of Neuropilin-1 but Not Neuropilin-2 J. Biol. Chem., October 17, 2008; 283(42): 28074 - 28080. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. J. Gray, G. Van Buren, N. A. Dallas, L. Xia, X. Wang, A. D. Yang, R. J. Somcio, Y. G. Lin, S. Lim, F. Fan, et al. Therapeutic Targeting of Neuropilin-2 on Colorectal Carcinoma Cells Implanted in the Murine Liver J Natl Cancer Inst, January 16, 2008; 100(2): 109 - 120. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Jaalouk, M. G. Ozawa, J. Sun, J. Lahdenranta, R. O. Schlingemann, R. Pasqualini, and W. Arap The Original Pathologische Anatomie Leiden-Endothelium Monoclonal Antibody Recognizes a Vascular Endothelial Growth Factor Binding Site within Neuropilin-1 Cancer Res., October 15, 2007; 67(20): 9623 - 9629. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Geretti, A. Shimizu, P. Kurschat, and M. Klagsbrun Site-directed Mutagenesis in the B-Neuropilin-2 Domain Selectively Enhances Its Affinity to VEGF165, but Not to Semaphorin 3F J. Biol. Chem., August 31, 2007; 282(35): 25698 - 25707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Vander Kooi, M. A. Jusino, B. Perman, D. B. Neau, H. D. Bellamy, and D. J. Leahy Structural basis for ligand and heparin binding to neuropilin B domains PNAS, April 10, 2007; 104(15): 6152 - 6157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Ellis The role of neuropilins in cancer Mol. Cancer Ther., May 1, 2006; 5(5): 1099 - 1107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kurschat, D. Bielenberg, M. Rossignol-Tallandier, A. Stahl, and M. Klagsbrun Neuron Restrictive Silencer Factor NRSF/REST Is a Transcriptional Repressor of Neuropilin-1 and Diminishes the Ability of Semaphorin 3A to Inhibit Keratinocyte Migration J. Biol. Chem., February 3, 2006; 281(5): 2721 - 2729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. El-Sheikh, P. Borgstrom, G. Bhattacharjee, M. Belting, and T. S. Edgington A Selective Tumor Microvasculature Thrombogen that Targets a Novel Receptor Complex in the Tumor Angiogenic Microenvironment Cancer Res., December 1, 2005; 65(23): 11109 - 11117. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Vallbohmer, W. Zhang, M. Gordon, D. Y. Yang, J. Yun, O. A. Press, K. E. Rhodes, A. E. Sherrod, S. Iqbal, K. D. Danenberg, et al. Molecular Determinants of Cetuximab Efficacy J. Clin. Oncol., May 20, 2005; 23(15): 3536 - 3544. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Gray, J. S. Wey, A. Belcheva, M. F. McCarty, J. G. Trevino, D. B. Evans, L. M. Ellis, and G. E. Gallick Neuropilin-1 Suppresses Tumorigenic Properties in a Human Pancreatic Adenocarcinoma Cell Line Lacking Neuropilin-1 Coreceptors Cancer Res., May 1, 2005; 65(9): 3664 - 3670. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
